[Diabetic retinopathy in the Czech National Diabetes Programme 2012-2022].
Diabetic retinopathy (DR) develops in patients with both type 1 and type 2 diabetes and is the major cause of vision loss and blindness in people of working age. In the Czech Republic, the number of patients with diabetic retinopathy is still increasing as well as the number of diabetic patients. It is known, that the comprehensive preventive and therapeutic procedures reduce the risk of visual loss by more than 90%. These procedures include intervention of modifiable risk factors (especially hypertension and hyperglycaemia), active screening of DR and specialized ophthalmologic treatment. The Czech National Diabetes Programme 2012-2022, which is built on similar initiatives as in 1984 and 2000, has been completed in late 2012. Its main goal is to improve the health outcomes for people diabetes in the Czech Republic. The programme includes specific procedures aimed at improvement of organization and treatment providing to patients with diabetic retinopathy.